Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix reported Q3 2025 results, showing revenue of $7.99 million and a gross profit of $1.40 million. Operating loss was $46.97 million, and net loss was $53.71 million. Year‑to‑date revenue reached $20.56 million with a net loss of $121.75 million.
Liquidity strengthened during the quarter: cash and cash equivalents were $335.50 million, with short‑term investments of $223.32 million and long‑term investments of $89.45 million. The company issued $360.0 million of 2030 convertible senior notes and purchased capped calls for $45.29 million. Warrant exercises generated $232.11 million in gross proceeds, and Enovix repurchased 5,437,556 shares for $58.39 million.
Total assets were $913.71 million and long‑term debt, net, was $518.35 million. Shares outstanding were 215,816,004 as of November 3, 2025. Management states current cash, cash equivalents and investments are expected to meet anticipated needs for at least the next twelve months.
Enovix Corporation furnished an update on its third-quarter 2025 results. The company announced that it issued a press release with financial results for the quarter, and attached it as Exhibit 99.1.
The disclosure was furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless specifically referenced.
Enovix (ENVX) reported an insider equity transaction by its Chief Legal Officer, who had shares withheld to cover taxes tied to restricted stock unit (RSU) vesting. On October 24, 2025, 2,216 shares of common stock were withheld at a price of $12.32 under transaction code “F.”
Following the transaction, the officer beneficially owns 424,969 shares. This includes 309,236 shares issuable upon future RSU vesting and settlement, and 20,786 vested performance RSUs, with 50% scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027. Each RSU and PRSU represents a contingent right to receive one share of common stock.
Enovix (ENVX) reported an insider transaction by President and CEO and Director Raj Talluri tied to restricted stock unit (RSU) vesting. On 10/18/2025, a Form 4 shows a code F transaction reflecting the withholding of 17,618 shares of common stock at $11.21 to satisfy tax obligations from RSU vesting.
Following the transaction, Talluri beneficially owns 2,317,219 shares directly. This figure includes 1,715,747 shares issuable upon settlement of RSUs granted to him and 95,551 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027. Each RSU and PRSU represents a contingent right to receive one share upon settlement.
Enovix Corporation (ENVX) reported an insider transaction by Chief Operating Officer Ajay Marathe. On October 14, 2025, 7,338 shares of common stock were withheld to satisfy tax obligations tied to RSU vesting, recorded as Code F at $12.87 per share.
After this transaction, Marathe beneficially owned 995,346 shares directly. His holdings include 760,521 shares issuable upon RSU settlement and 33,170 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) officer Kristina Truong reported Form 4 transactions tied to tax withholding on vested RSUs. On October 10, 2025, 252 shares were withheld at $12.07 (Code F). On October 13, 2025, 1,013 shares were withheld at $13.02 (Code F).
Following these transactions, beneficial ownership stands at 197,734 shares. The holdings include 157,865 shares issuable upon RSU vesting and 4,978 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) reporting officer Ajay Marathe disclosed transactions on
Enovix Corp (ENVX) Chief Legal Officer Arthi Chakravarthy reported a withholding sale of 4,287 shares on
The filing shows a routine tax-withholding disposition rather than an open-market sale, and it discloses the composition and timing of equity awards that form most of the reporting person's economic exposure to the company.
Raj Talluri, President and CEO of Enovix Corporation (ENVX), reported a non-derivative disposition of 17,925 shares of common stock on
After the withholding, the report shows beneficial ownership of 2,334,837 shares. That total includes 1,749,081 shares issuable upon settlement of RSUs and 95,551 performance RSUs (PRSUs), with 50% of the PRSUs scheduled to release on
Enovix Corp (ENVX) reporting person Kristina Truong, Chief Accounting Officer, disclosed a transaction on
The filing explains the sale reflects withholding to satisfy tax obligations from RSU vesting and that the reporting person holds 160,257 shares issuable from RSUs plus 4,978 vested performance RSUs, of which 50% will release on